Severe orthostatic hypotension during treatment of falciparum malaria.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000009:adverse effects*; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced*; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use; D013413:Sulfadoxine / Q000009:adverse effects / Q000627:therapeutic use
D000962:Antimalarials; D013413:Sulfadoxine; D011739:Pyrimethamine